Risk Factors for Surgical Site Infection and Association With Infliximab Administration During Surgery for Crohn’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk Factors for Surgical Site Infection and Association With Infliximab Administration During Surgery for Crohn’s Disease

Published:2013-10 Issue:10 Volume:56 Page:1156-1165
ISSN:0012-3706
Container-title:Diseases of the Colon & Rectum
language:en
Short-container-title:

Author:

Uchino Motoi,Ikeuchi Hiroki,Matsuoka Hiroki,Bando Toshihiro,Ichiki Kaoru,Nakajima Kazuhiko,Tomita Naohiro,Takesue Yoshio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,General Medicine

Reference19 articles.

1. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohns disease: a post-hoc analysis from ACCENT I.;Reinisch;Aliment Pharmacol Ther,2012

2. ACCENT I Study Group. Maintenance infliximab for Crohns disease: the ACCENT I randomised trial.;Hanauer;Lancet,2002

3. Early use of immunosuppressives or TNF antagonists for the treatment of Crohns disease: time for a change.;Ordas;Gut,2011

4. Serious infections and mortality in association with therapies for Crohns disease: TREAT registry.;Lichtenstein;Clin Gastroenterol Hepatol,2006

5. Perioperative treatment with infliximab in patients with Crohns disease and ulcerative colitis is not associated with an increased rate of postoperative complications.;Kunitake;J Gastrointest Surg,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis;Journal of the American Academy of Dermatology;2024-08

2. Incidence and risk factors of surgical site infection in abdominal surgeries: A scoping review of cohort and case–control studies;2023-08-29

3. Predictive value of laboratory markers in identifying postoperative complications among Crohn’s disease patients;Dokazatel'naya gastroenterologiya;2023

4. The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-22

5. ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD;Journal of Crohn's and Colitis;2022-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3